Confluence Life Sciences

Confluence Life Sciences, Inc.Established in 2010, Confluence Life Sciences, Inc. is headquartered in St. Louis, US. The company specializes in innovative solutions within the life sciences field., indicating a strategic pivot towards a more consolidated operational structure.Confluence Life Sciences, Inc. specializes in developing innovative technology solutions for the life sciences industry. Their core offerings include advanced software platforms and tools that optimize operational efficiency, enhance customer engagement, and facilitate data-driven decision-making. These solutions are designed to meet the specific needs of sectors like healthcare, finance, and manufacturing, effectively addressing challenges such as workflow inefficiencies and data silos.The revenue model of Confluence Life Sciences, Inc. includes a combination of subscription services and direct sales of its flagship products. Clients typically enter annual subscription agreements, which provide access to the company's software tools, including ongoing updates and support. This model features a tiered pricing structure, allowing clients to select plans that fit their needs and budgets. The company is designing new products aimed at improving operational processes in drug development, with anticipated releases in the coming year. Additionally, there are initiatives to penetrate new geographic markets, focusing on regions like Europe and Asia by the end of 2024. The recent acquisition by Aclaris Therapeutics, Inc. will provide the necessary resources to support these growth initiatives and solidify the company’s position within the industry.

1. Series A

   Oct 24, 2013

   Amount

   $0.5M

   Investors

   Locked

2. Series A

   Sep 17, 2012

   Amount

   $3.7M

   Investors

   Locked